Literature DB >> 552297

Validity of cross-over trials.

D W Vere.   

Abstract

Mesh:

Year:  1979        PMID: 552297      PMCID: PMC1429712          DOI: 10.1111/j.1365-2125.1979.tb05902.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  4 in total

1.  THE FEET OF CLAY OF THE DOUBLE-BLIND TRIAL.

Authors:  B W CROMIE
Journal:  Lancet       Date:  1963-11-09       Impact factor: 79.321

2.  The self-controlled and self-recorded clinical trial for low-grade morbidity.

Authors:  L HOGBEN; M SIM
Journal:  Br J Prev Soc Med       Date:  1953-10

3.  A longitudinal study of the mechanisms of action of debrisoquine and propranolol.

Authors:  J Aminu; D W Vere
Journal:  Br J Clin Pharmacol       Date:  1978-07       Impact factor: 4.335

4.  The two-period cross-over clinical trial.

Authors:  M Hills; P Armitage
Journal:  Br J Clin Pharmacol       Date:  1979-07       Impact factor: 4.335

  4 in total
  4 in total

1.  Clinical trials, statistics, and dilemmas.

Authors:  S McKenzie
Journal:  Arch Dis Child       Date:  1988-03       Impact factor: 3.791

2.  The search for more clinically meaningful research designs: single-patient randomized clinical trials.

Authors:  M S Porta
Journal:  J Gen Intern Med       Date:  1986 Nov-Dec       Impact factor: 5.128

Review 3.  Assessment of extrapyramidal disorders.

Authors:  C D Marsden; M Schachter
Journal:  Br J Clin Pharmacol       Date:  1981-02       Impact factor: 4.335

Review 4.  Unconventional viral gene expression mechanisms as therapeutic targets.

Authors:  Jessica Sook Yuin Ho; Zeyu Zhu; Ivan Marazzi
Journal:  Nature       Date:  2021-05-19       Impact factor: 49.962

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.